Traumatic brain injury, abnormal growth hormone secretion, and gut dysbiosis

Elsevier

Available online 19 November 2023, 101841

Best Practice & Research Clinical Endocrinology & MetabolismAuthor links open overlay panel, , , , , , , , , Summary

The gut microbiome has been implicated in a variety of neuropathologies with recent data suggesting direct effects of the microbiome on host metabolism, hormonal regulation, and pathophysiology. Studies have shown that gut bacteria impact host growth, partially mediated through the growth hormone (GH)/insulin-like growth factor 1 (IGF-1) axis. However, no study to date has examined the specific role of GH on the fecal microbiome (FMB) or the changes in this relationship following a traumatic brain injury (TBI). Current literature has demonstrated that TBI can lead to either temporary or sustained abnormal GH secretion (aGHS). More recent literature has suggested that gut dysbiosis may contribute to aGHS leading to long-term sequelae now known as brain injury associated fatigue and cognition (BIAFAC). The aGHS observed in some TBI patients presents with a symptom complex including profound fatigue and cognitive dysfunction that improves significantly with exogenous recombinant human GH treatment. Notably, GH treatment is not curative as fatigue and cognitive decline typically recur upon treatment cessation, indicating the need for additional studies to address the underlying mechanistic cause.

Section snippetsTraumatic Brain Injury

Traumatic brain injury (TBI) is a leading cause of death and disability affecting an estimated 64-74 million people worldwide yearly [1]. In 2016, the US Department of Defense defined TBI as “a traumatically induced structural injury and/or physiological disruption of brain function as a result of an external force that is indicated by new onset or worsening of at least one of the following clinical signs immediately following the event: alteration in mental status, loss of memory for events

Abnormal Growth Hormone Secretion (aGHS)

Hypopituitarism as a result of TBI was reported more than 65 years ago [14]. Since that time, there have been numerous studies that have reported significant numbers of patients with post-TBI anterior pituitary dysfunction affecting as many as 40-50% of those with severe TBI [15], [16]. A substantial number of studies examined anterior pituitary hormone levels acutely with a limited number reporting impacts beyond six months (acute phase) following the initial TBI [15].

While the pathophysiology

Brain Injury Associated Fatigue and Altered Cognition (BIAFAC)

BIAFAC syndrome was formally described in 2020 [24]. This syndrome describes patients with a history of TBI of all severities who develop chronic fatigue, brain fog, and sleep difficulties that persist months to years after injury [24]. Diagnostically, maximal GH secretion of <10 ng/mL in response to glucagon stimulation was consistently observed in symptomatic patients [24], hence, a peak response <10 ng/mL was used as a threshold for BIAFAC diagnosis for patients with a history of TBI and

Gut dysbiosis and the Microbiota-Gut-Brain Axis

A new and rapidly expanding field of research suggests that gut bacteria influences brain and endocrine functions via an interaction termed the microbiota-gut-brain axis [48]. This axis (Fig. 2) has been associated with a growing number of neuropathologies and is now understood to exert remarkable control over human health, mood and possibly behavior [48]. Dietary modifications, infections, injuries, and changes to the GI mucosa can shift the gut microbiome to a dysbiotic state with pronounced

Conclusions

Both acute and long-term effects of TBI are a growing public health concern worldwide. TBIs are common in athletes, military personnel as well as in the general population, and can lead to debilitating fatigue, altered cognition, and altered GH secretion as seen in BIAFAC patients. Individuals with BIAFAC find it difficult to perform their jobs or succeed in school and frequently seek alternate positions with less hours or take leaves of absence to accommodate their symptoms. Many BIAFAC

Uncited reference

[25]

Acknowledgements

The figures were created with BioRender.com. Fig. 1 was adapted from the “Anterior Pituitary Hormones” template, Fig. 4 was adapted from the “Metabolism of SCFAs” after retrieval from https://app.biorender.com/biorender-templates.

CONLICT OF INTEREST

The authors have no conflicts of interest to declare related to this publication.

References (83)L. Liu et al.Microbiota and the gut-brain-axis: Implications for new therapeutic design in the CNS

EBioMedicine

(2022)

S.M. FinegoldDesulfovibrio species are potentially important in regressive autism

Med. Hypotheses

(2011)

S. Soriano et al.Alterations to the gut microbiome after sport-related concussion in a collegiate football players cohort: A pilot study

Brain Behav Immun Health

(2022)

L. Chen et al.The long-term genetic stability and individual specificity of the human gut microbiome

Cell

(2021)

M.C. Dewan et al.Estimating the global incidence of traumatic brain injury

J. Neurosurg.

(2018)

Statements Q. VA/DoD CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF CONCUSSION-MILD TRAUMATIC BRAIN...G. Ilie et al.Prevalence and correlates of traumatic brain injuries among adolescents

JAMA

(2013)

W.M. **High et al.Effect of growth hormone replacement therapy on cognition after traumatic brain injury

J. Neurotrauma

(2010)

R.J. **UrbanHypopituitarism after acute brain injury

Growth Horm. IGF Res.

(2006)

J. Daugherty et al.Traumatic Brain Injury-Related Deaths by Race/Ethnicity, Sex, Intent, and Mechanism of Injury - United States, 2000-2017

MMWR Morb. Mortal. Wkly. Rep.

(2019)

A. BiegonConsidering Biological Sex in Traumatic Brain Injury

Front. Neurol.

(2021)

A.B. Peterson et al.Incidence of Nonfatal Traumatic Brain Injury-Related Hospitalizations - United States, 2018

MMWR Morb. Mortal. Wkly. Rep.

(2021)

B.M. Bloom et al.Short-term neurocognitive and symptomatic outcomes following mild traumatic brain injury: A prospective multi-centre observational cohort study

Brain Inj

(2017)

D. Pavlovic et al.Traumatic brain injury: neuropathological, neurocognitive and neurobehavioral sequelae

Pituitary

(2019)

D.J. **Zgaljardic et al.Posttraumatic Hypopituitarism: Neuroendocrine Dysfunction and TreatmentL.Y. Leung et al.The acute effects of hemorrhagic shock on cerebral blood flow, brain tissue oxygen tension, and spreading depolarization following penetrating ballistic-like brain injury

J. Neurotrauma

(2013)

J.F. Malec et al.The mayo classification system for traumatic brain injury severity

J. Neurotrauma

(2007)

M. Schneider et al.Anterior pituitary hormone abnormalities following traumatic brain injury

J. Neurotrauma

(2005)

G. Owens et al.Clinical presentation and diagnosis: growth hormone deficiency in adults

Am. J. Manag. Care

(2004)

V. Gasco et al.Hypopituitarism following brain injury: when does it occur and how best to test?

Pituitary

(2012)

G. Osterstock et al.Sustained alterations of hypothalamic tanycytes during posttraumatic hypopituitarism in male mice

Endocrinology

(2014)

S. Temizkan et al.A clinical and pathophysiological approach to traumatic brain injury-induced pituitary dysfunction

Pituitary

(2019)

W.J. **Durham et al.Hypoaminoacidemia Characterizes Chronic Traumatic Brain Injury

J. Neurotrauma

(2017)

R.J. **UrbanA Treatable Syndrome in Patients with Traumatic Brain Injury

J. Neurotrauma

(2020)

K.C.J. **YuenGrowth Hormone Stimulation Tests in Assessing Adult Growth Hormone Deficiency

(2023)

R. Graham et al.Committee on Sports-Related Concussions, Board on Children, Youth, and Families, Institute of Medicine, National Research CouncilTreatment and Management of Prolonged Symptoms and Post-Concussion Syndrome

(2014)

F. Lauzier et al.Clinical outcomes, predictors, and prevalence of anterior pituitary disorders following traumatic brain injury: a systematic review

Crit. Care Med.

(2014)

E.E. Coris et al.Stimulant Therapy Utilization for Neurocognitive Deficits in Mild Traumatic Brain Injury

Sports Health

(2022)

D.L. Warden et al.Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury

J. Neurotrauma

(2006)

N. Kreitzer et al.The Effect of Antidepressants on Depression After Traumatic Brain Injury: A Meta-analysis

J. Head Trauma Rehabil.

(2019)

C. Eccleston et al.Psychological therapies for the management of chronic and recurrent pain in children and adolescents

Cochrane Database Syst. Rev.

(2012)

View full text

© 2023 Published by Elsevier Ltd.

留言 (0)

沒有登入
gif